Abstract
In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Reviews on Recent Clinical Trials
Title:What About the Neuroimaging Findings in Social Anxiety Disorder?
Volume: 8 Issue: 2
Author(s): Murad Atmaca
Affiliation:
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Abstract: In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Export Options
About this article
Cite this article as:
Atmaca Murad, What About the Neuroimaging Findings in Social Anxiety Disorder?, Reviews on Recent Clinical Trials 2013; 8 (2) . https://dx.doi.org/10.2174/15748871113086660050
DOI https://dx.doi.org/10.2174/15748871113086660050 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Voltage Gated Calcium Channels as Targets for Analgesics
Current Topics in Medicinal Chemistry NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Understanding Stem Cell-Mediated Brain Repair Through Neuroimaging
Current Stem Cell Research & Therapy The Role of T-Type Calcium Channels in Epilepsy and Pain
Current Pharmaceutical Design Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study
Current Alzheimer Research Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Cardioregulatory Functions of Neuropeptides and Peptide Hormones in Insects
Protein & Peptide Letters Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders
CNS & Neurological Disorders - Drug Targets Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
Current Pharmaceutical Design The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Current Alzheimer Research The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Current Alzheimer Research Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Serotonin Receptors, Type 4: A New Hope?
Current Drug Targets Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
Current Drug Delivery Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest
Current Alzheimer Research Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design New Therapeutic Frontiers for Metabotropic Glutamate Receptors
Current Topics in Medicinal Chemistry